This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vermeersch, P. Articles by Van Langenhove, G. Search for Related Content PubMed Articles by Vermeersch, P. Articles by Van Langenhove, G.

Randomized Double-Blind Comparison of Sirolimus-Eluting Stent Versus Bare-Metal Stent Implantation in Diseased Saphenous Vein Grafts

Six-Month Angiographic, Intravascular Ultrasound, and Clinical Follow-Up of the RRISC Trial

Paul Vermeersch, MD^_*,_*, Pierfrancesco Agostoni, MD^_*, Stefan Verheye, MD, PhD^_*, Paul Van den Heuvel, MD^_*, Carl Convens, MD^_*, Nico Bruining, PhD, Frank Van den Branden, MD^_* and Glenn Van Langenhove, MD, PhD^_*

^_* Antwerp Cardiovascular Institute Middelheim, AZ Middelheim, Antwerp, Belgium
Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands. Drs. Vermeersch and Agostoni contributed equally to this work

View larger version (22K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Complete flowchart of the patients enrolled in the RRISC (Reduction of Restenosis In Saphenous vein grafts with Cypher sirolimus-eluting stent) trial. BMS = bare-metal stent; MI = myocardial infarction; RVD = reference vessel diameter; SES = sirolimus-eluting stent.